van der Starre P, Sinclair D, Damen J, Brummelhuis H
J Thorac Cardiovasc Surg. 1980 May;79(5):738-40.
The hypotensive effect of stable plasma protein solution (SPPS) is a well-known phenomenon, causing serious problems in surgical patients and patients supported by cardiopulmonary bypass. Kinins are believed to be responsible. A study was made to prevent this hypotension by adding C1 esterase inhibitor to the SPPS and comparing this with 5% human albumin. The results shows a significant difference between the effects of SPPS and SPPS plus C1 esterase inhibitor infusion on bypass. Five percent human albumin did not cause hypotension. Possible sequelae are discussed.
稳定血浆蛋白溶液(SPPS)的降压作用是一个众所周知的现象,在外科手术患者和接受体外循环支持的患者中会引发严重问题。激肽被认为是其原因。开展了一项研究,通过在SPPS中添加C1酯酶抑制剂来预防这种低血压,并将其与5%人白蛋白进行比较。结果显示,SPPS与输注了C1酯酶抑制剂的SPPS在体外循环中的作用存在显著差异。5%人白蛋白不会导致低血压。文中讨论了可能的后遗症。